Leukemia
📧 Sign up to get email alerts when something new happens for Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-07-30Clinical Trial Update: Open Dose Escalating Trial to Determine the Maximum Tolerated Dose in Paediatric Patients With Advanced Cancers for Whom no Therapy is Known [Phase 1]
A Phase 1 open-dose escalation trial in pediatric patients with advanced cancers lacking standard therapy has completed, with results posted…
-
CLINICAL_TRIALS trial_result · 2018-07-13Clinical Trial Update: Evaluation of ClearLLab Leukemia and Lymphoma Panels
Completed clinical trial evaluating Beckman Coulter's ClearLLab leukemia and lymphoma panels for diagnostic use in leukemia and lymphoma con…
-
CLINICAL_TRIALS trial_result · 2018-07-10Clinical Trial Update: Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine [Phase 2]
Phase 2 trial evaluating hematopoietic stem cell transplantation after a chemotherapy-only cytoreduction with busulfan, cyclophosphamide, an…
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers [Phase 2]
Phase 2 trial evaluating reduced-intensity, related-donor bone marrow transplantation followed by high-dose cyclophosphamide for hematologic…
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Evaluation of Loratadine for G-CSF Induced Bone Pain in Patients With Hematologic Malignancies
The document reports the completion and update of a clinical trial evaluating loratadine for G-CSF–induced bone pain in patients with leukem…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-06-25Clinical Trial Update: Phase I Dose Escalation of BAY1143572 in Subjects With Acute Leukemia [Phase 1]
Phase I dose-escalation trial of BAY1143572 in subjects with acute leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-07Clinical Trial Update: Interferon α for the Therapy of Minimal Residual Disease [NA]
Clinical trial update investigating interferon alpha for treating minimal residual disease in leukemia.
-
CLINICAL_TRIALS trial_result · 2018-05-31Clinical Trial Update: Clofarabine Plus Low-Dose Cytarabine for Patients With Higher-Risk Myelodysplastic Syndrome (MDS) [Phase 2]
Phase 2 clinical trial evaluating clofarabine plus low-dose cytarabine in higher-risk myelodysplastic syndromes has completed and results we…
-
CLINICAL_TRIALS trial_result · 2018-05-31Clinical Trial Update: RAD001 Study in Treatment of Relapsed or Refractory Acute Lymphocytic Leukemia [Phase 1, Phase 2]
Clinical trial update for RAD001 in relapsed or refractory acute lymphocytic leukemia (ALL) completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-05-24Clinical Trial Update: Allogeneic Transplant in HIV Patients (BMT CTN 0903) [Phase 2]
Phase 2 clinical trial evaluating allogeneic transplant in HIV-positive patients with leukemia or lymphoma; completed with results posted in…
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: Feasibility of Activity Monitoring in Patients With Cancer: Physical Activity Monitoring in Cancer Patients (PAMCaP)
The PAMCaP trial update reports the completion of a feasibility study evaluating physical activity monitoring in cancer patients. The resear…
-
CLINICAL_TRIALS trial_result · 2018-05-01Clinical Trial Update: Safety and Efficacy Evaluation of IM19 CAR-T Cells [Phase 1, Phase 2]
This document provides an update on the safety and efficacy evaluation of IM19 CAR-T Cells in leukemia across Phase 1 and Phase 2 trials.
-
CLINICAL_TRIALS trial_result · 2018-04-30Clinical Trial Update: Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients [Phase 2]
Phase 2 trial evaluating a three-drug regimen (Tacrolimus, Bortezomib, and Thymoglobulin) to prevent low-toxicity graft-versus-host disease …
-
CLINICAL_TRIALS trial_result · 2018-04-25Clinical Trial Update: Clofarabine and Non-Myeloablative Allogeneic Hematopoietic Transplantation [Phase 1, Phase 2]
A phase 1/2 trial of Clofarabine combined with non-myeloablative allogeneic hematopoietic transplantation was terminated, with results poste…
-
CLINICAL_TRIALS trial_result · 2018-04-25Clinical Trial Update: Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSF [Phase 1]
Phase 1 study evaluating mobilization of autologous peripheral blood stem cells using interleukin-2 and GM-CSF; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-23Clinical Trial Update: Bortezomib for Low or Intermediate-1 Myelodysplastic Syndrome (MDS) With p65 Activation [Phase 2]
A Phase 2 clinical trial of bortezomib in patients with low or intermediate-1 myelodysplastic syndrome with p65 activation has completed, wi…
-
CLINICAL_TRIALS trial_result · 2018-04-23Clinical Trial Update: Pacritinib for Patients With Lower-Risk Myelodysplastic Syndromes (MDS) [Phase 2]
Phase 2 trial update for pacritinib in lower-risk myelodysplastic syndromes has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Study of VELCADE® With Mitoxantrone and Etoposide for Leukemias [Phase 1, Phase 2]
This clinical trial update reports Phase 1/2 results for a combination of bortezomib (Velcade) with mitoxantrone and etoposide in relapsed o…
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor [NA]
Clinical trial update on biparental HLA haplotype disparate T-cell depleted transplants for patients without an HLA-compatible donor has bee…
-
CLINICAL_TRIALS trial_result · 2018-04-11Clinical Trial Update: Vorinostat in Children [Phase 1, Phase 2]
Completed Phase 1/2 clinical trial evaluating vorinostat in pediatric patients with relapsed solid tumors, lymphoma, or leukemia.
-
CLINICAL_TRIALS trial_result · 2018-04-03Clinical Trial Update: Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer [Phase 2]
Phase 2 clinical trial evaluating busulfan, cyclophosphamide, and antithymocyte globulin followed by stem cell transplant for hematologic ca…
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: Multicenter Trial to Treat Patients With Relapsed/Refractory Aggressive Non Hodgkin Lymphoma [Phase 2]
A multicenter Phase 2 trial sponsored by PharmaMar for relapsed/refractory aggressive non-Hodgkin lymphoma has completed enrollment and post…
-
CLINICAL_TRIALS trial_result · 2018-03-27Clinical Trial Update: Intrathecal Rituximab in Lymphoid Malignancies Involving Central Nervous System [Phase 1, Phase 2]
A phase 1/2 trial of intrathecal rituximab for lymphoid malignancies involving the central nervous system was terminated with results posted…
-
CLINICAL_TRIALS trial_result · 2018-03-22Clinical Trial Update: PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous Thromboembolism
The PENELOPE observational study, which examined prophylaxis and treatment of arterial and venous thromboembolism in patients with hematolog…
-
CLINICAL_TRIALS trial_result · 2018-03-16Clinical Trial Update: Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies [Phase 2]
Phase 2 trial of non-myeloablative HLA-mismatched ex-vivo T-cell depleted stem cell transplantation for hematologic malignancies was termina…